Antinephrin Antibodies in IgAN: Toward a Phenotype-Driven, Personalized Approach.

1 are encouraging, but must be read with caution: seropositive patients were also far more likely to receive glucocorticoids; so treatment-selection bias cannot be excluded, and the multivariable model showed only a nonsignificant trend toward higher complete remission.

also in 5,406 other papers